NEWS IN BRIEF
Biologics CDMO completes €5m expansion in Spain
Biologics and cell therapy CDMO, 3P Biopharmaceuticals, has expanded its facility and capabilities in Pamplona, Spain.
Archives for December 18, 2018
Herceptin biosimilar market expands with Celltrion-Teva approval
The US regulator has validated Celltrion and Teva’s biosimilar version of Roche’s Herceptin, marking the partnership’s second approval in as many months.
Amgen enters licensing agreement to use oral formulation platform
Entera will use its proprietary drug delivery platform to progress Amgen’s preclinical programs into oral formulations.